Deadline: May 11, 2020 and May 11, 2021
The National institute of Allergy and Infectious Diseases (NIAID) recently published a Program Announcement (PAR-20-054). The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research among transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).
Applications are due May 11, 2020 and May 11, 2021. Please click here for more information.